Yifan Lian

1.9k citations
52 papers · 1.4k indexed · h-index 22
    • Cancer-related molecular mechanisms research 19
    • MicroRNA in disease regulation 5
    • RNA modifications and cancer 15
    • RNA Research and Splicing 8
  • Hepatology top 10%
    • Hepatitis C virus research 6
    • Hepatitis B Virus Studies 9
    • Liver Disease Diagnosis and Treatment 6
    • Cancer-related Molecular Pathways 5

Yifan Lian

49 papers receiving 1.4k citations

Peers

Yifan Lian
Comparison fields: 5 of 72
  • Cancer Research 1.0k
  • Molecular Biology 1.1k
  • Hepatology 64
  • Epidemiology 188
  • Oncology 148
Replace Zhe Yang with:
Zhe Yang China
Ming-hua Zhu China
Chenlong Song China
Guoliang Ye China
Chung-Ta Lee Taiwan
Daniela Pollutri Italy
Sho Nambara Japan
Alma D. Campos-Parra Mexico
Yifan Lian relative to Zhe Yang China Zhe Yang's profile →
Citations per field
00.5×1.5×
Zhe Yang · 1×
Citations per year

Countries citing papers authored by Yifan Lian

Since Specialization
Citations

This map shows the geographic impact of Yifan Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifan Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifan Lian more than expected).

Fields of papers citing papers by Yifan Lian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifan Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifan Lian. The network helps show where Yifan Lian may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yifan Lian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yifan Lian Line = papers co-authored together Yifan Lian links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 202435
3 20243
4 20240
5 202310
6 202210
7 202210
8 20201
9 202013
10 202011
11 201915
12 201936
13 201943
14 201935
15 201927
16 20184
17 201745
18 201676
19 201547
20 2015137

About Yifan Lian

Yifan Lian is a scholar working on Cancer Research, Hepatology and Molecular Biology, having authored 52 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (19 papers), RNA modifications and cancer (15 papers), Hepatitis B Virus Studies (9 papers), RNA Research and Splicing (8 papers), Liver Disease Diagnosis and Treatment (6 papers), Hepatitis C virus research (6 papers), MicroRNA in disease regulation (5 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Cancer Research (1.0k citations), Molecular Biology (1.1k citations) and Hepatology (64 citations). Yifan Lian has collaborated with scholars based in China, South Korea and United Kingdom. Frequent co-authors include Hao Ji, Yuehua Huang, Ke‐Ming Wang, Yanlin Huang, Yong-Guo Shi, Hongzhi Xu, Zeling Cai, Changsheng Yan, Yingrui Fan and Keming Wang. Their work appears in journals such as The Science of The Total Environment, Oncogene and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026